161 related articles for article (PubMed ID: 18597510)
1. Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.
Boswell CA; Regino CA; Baidoo KE; Wong KJ; Bumb A; Xu H; Milenic DE; Kelley JA; Lai CC; Brechbiel MW
Bioconjug Chem; 2008 Jul; 19(7):1476-84. PubMed ID: 18597510
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
4. New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
Org Biomol Chem; 2015 Dec; 13(46):11302-14. PubMed ID: 26419637
[TBL] [Abstract][Full Text] [Related]
5. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms.
Ferdani R; Stigers DJ; Fiamengo AL; Wei L; Li BT; Golen JA; Rheingold AL; Weisman GR; Wong EH; Anderson CJ
Dalton Trans; 2012 Feb; 41(7):1938-50. PubMed ID: 22170043
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling.
Cai H; Fissekis J; Conti PS
Dalton Trans; 2009 Jul; (27):5395-400. PubMed ID: 19565091
[TBL] [Abstract][Full Text] [Related]
8. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
[TBL] [Abstract][Full Text] [Related]
9. New macrobicyclic chelator for the development of ultrastable 64Cu-radiolabeled bioconjugate.
Pandya DN; Dale AV; Kim JY; Lee H; Ha YS; An GI; Yoo J
Bioconjug Chem; 2012 Mar; 23(3):330-5. PubMed ID: 22329542
[TBL] [Abstract][Full Text] [Related]
10. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
Guo Y; Ferdani R; Anderson CJ
Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
[TBL] [Abstract][Full Text] [Related]
12. Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.
Seo JW; Mahakian LM; Kheirolomoom A; Zhang H; Meares CF; Ferdani R; Anderson CJ; Ferrara KW
Bioconjug Chem; 2010 Jul; 21(7):1206-15. PubMed ID: 20568726
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents.
Sprague JE; Peng Y; Fiamengo AL; Woodin KS; Southwick EA; Weisman GR; Wong EH; Golen JA; Rheingold AL; Anderson CJ
J Med Chem; 2007 May; 50(10):2527-35. PubMed ID: 17458949
[TBL] [Abstract][Full Text] [Related]
14. A novel side-bridged hybrid phosphonate/acetate pendant cyclam: synthesis, characterization, and 64Cu small animal PET imaging.
Boswell CA; Regino CA; Baidoo KE; Wong KJ; Milenic DE; Kelley JA; Lai CC; Brechbiel MW
Bioorg Med Chem; 2009 Jan; 17(2):548-52. PubMed ID: 19101152
[TBL] [Abstract][Full Text] [Related]
15. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes.
Juran S; Walther M; Stephan H; Bergmann R; Steinbach J; Kraus W; Emmerling F; Comba P
Bioconjug Chem; 2009 Feb; 20(2):347-59. PubMed ID: 19173600
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.
Wadas TJ; Anderson CJ
Nat Protoc; 2006; 1(6):3062-8. PubMed ID: 17406569
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.
Jiang M; Ferdani R; Shokeen M; Anderson CJ
Nucl Med Biol; 2013 Feb; 40(2):245-51. PubMed ID: 23265977
[TBL] [Abstract][Full Text] [Related]
18. Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.
Anderson CJ; Wadas TJ; Wong EH; Weisman GR
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):185-92. PubMed ID: 18043536
[TBL] [Abstract][Full Text] [Related]
19. Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.
Persson M; Hosseini M; Madsen J; Jørgensen TJ; Jensen KJ; Kjaer A; Ploug M
Theranostics; 2013; 3(9):618-32. PubMed ID: 24052804
[TBL] [Abstract][Full Text] [Related]
20. Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS.
Boswell CA; McQuade P; Weisman GR; Wong EH; Anderson CJ
Nucl Med Biol; 2005 Jan; 32(1):29-38. PubMed ID: 15691659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
